Partner 7 – BHAM
The Partner includes NIHR Biomedical Research Unit for Liver Disease (NIHR Liver BRU) and the Cancer Research UK Clinical Trials Unit (CRCTU), at the University of Birmingham. The CRCTU is one of the largest cancer trials units in the UK. It is NCRI accredited and UKCRN registered and receives core funding from Cancer Research UK. It designs, conducts and analyses national and international phase I-IV clinical trials. The Birmingham NIHR BRU in Liver Disease, established in 2008 with funding secured until 2017 (total NIHR funding of £13million), translates advances in basic science into novel therapies for liver disease and liver cancer. The BRU bridges the Centre for Liver Research at UoB with the Liver unit at the Queen Elizabeth Hospital. The latter has one of the largest liver transplant programmes in Europe (160+ transplants per year) and is a regional centre for the treatment of hepatocellular carcinoma. Both Units are funded by competitive national peer reviewed grants both recently extended to 2017.
Prof. David Adams